This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Acne  • Hypersensitivity  • Drug Therapy  • Adverse Effects  • Facial Plastic Surgery  • Dermabrasion/ Chemical Peels  • Allergy  • Alert me on articles by topic  Social Bookmarking   What's this?

Jennifer Channual, BS; Jashin J. Wu, MD; Christopher B. Zachary, MBBS, FRCP

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The lidocaine, 7%/tetracaine, 7%, cream Pliaglis (Galderma Laboratories, Fort Worth, Texas) (hereinafter, "LT peel") is a novel topical anesthetic cream that forms a self-occlusive, pliable membrane on exposure to air. The LT peel has been shown to be a safe and effective form of local anesthesia for various dermatologic procedures.¹ Minimal adverse effects associated with the LT peel have been reported, limited primarily to transient skin erythema with or without skin discoloration or edema.¹ Herein, we report a case of contact urticaria and discuss possible causes of such allergic manifestations and potential hazards and precautions recommended with the use of the LT peel.

Report of a Case

A 26-year-old nonatopic woman developed erythema and edema of the face and angioedema of the lips 15 minutes after application of the LT peel to her entire face prior to laser treatment for acne scarring. . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?